Filing Flows › Neuroone Medical Technologies (NMTC) › Q2 FY26 › vs Q1 FY26
Neuroone Medical Technologies (NMTC) Q2 FY26 vs Q1 FY26 (quarter over quarter)
Neuroone Medical Technologies's revenue fell $1.0M (-36%) from $2.9M in Q1 FY26 to $1.9M in Q2 FY26.
Neuroone Medical Technologies, Q2 FY26: revenue $1.9M (+34% year over year), operating margin -128.7%, net loss $2.4M, operating cash flow −$1.3M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $1.9M | $2.9M | −$1.0M | -36% |
| Other income, net | $15K | $269K | −$254K | -94% |
| Net loss | $2.4M | $1.4M | $944K | +66% |
| Costs & expenses | $4.3M | $4.6M | −$341K | -7% |
| Operating costs | $4.3M | $4.6M | −$341K | -7% |
| Cost of revenue | $872K | $1.3M | −$453K | -34% |
| Research & development | $1.5M | $1.4M | $78K | +6% |
| SG&A | $1.9M | $1.9M | $34K | +2% |
| Operating cash sources | $2.4M | $1.4M | $944K | +66% |
| Depreciation & amortization | $60K | $66K | −$5K | -8% |
| Share-based compensation | $342K | $359K | −$17K | -5% |
| Working capital & other | $651K | −$2.1M | $2.8M | — |
| Cash used in operations | $1.3M | $3.1M | −$1.8M | -57% |
| Net loss absorbed | $2.4M | $1.4M | $944K | +66% |
Questions
How much did Neuroone Medical Technologies's revenue grow quarter over quarter in Q2 FY26?
Neuroone Medical Technologies's revenue fell $1.0M (-36%) from $2.9M in Q1 FY26 to $1.9M in Q2 FY26.